Filter Content:

News

9 May 2017

Weight Cycling and Coronary Artery Disease

THE IMPACT of ‘weight cycling’ (here referring to repeated cycles of weight gain and loss) on health outcomes in patients with pre-existing heart disease…

9 May 2017

Muscle Stem Cells Used to Treat Heart Failure

A CUTTING-EDGE technique for the treatment of heart failure was revealed to have encouraging results in humans following a recent Phase I trial…

9 May 2017

Introducing EMJ Urology 5.1

United Kingdom, May 09, 2017: Welcome to the newest edition of our EMJ Urology eJournal, packed with the latest urological developments. This issue is…

9 May 2017

New Markers Predict Accelerated Diabetic Eye Disease!

Diabetic retinopathy (DR) is one of the late complications of diabetes and it usually affects people who have had diabetes for a considerable duration of…

5 May 2017

Relvar Ellipta Significantly Improved Asthma Control in Salford Lung Study Patients Compared with Their Usual Care

GlaxoSmithKline plc and Innoviva Inc today announced positive results from the innovative Salford Lung Study (SLS) in asthma.

5 May 2017

Osimertinib Improves Symptoms in Advanced Lung Cancer Patients

Osimertinib improves cancer-related symptoms in patients with advanced lung cancer, according to an analysis presented at the ELCC.

5 May 2017

White Blood Cell Count Predicts Response to Lung Cancer Immunotherapy

Geneva, Switzerland, 05 May 2017 – White blood cell counts can predict whether or not lung cancer patients will benefit from immunotherapy, according to…

Reproductive Health

4 May 2017

AlzProtect : The American Food and Drug Administration (FDA) Has Granted AZP2006 the Orphan Drug Designation for the Treatment of Progressive Supranuclear Palsy (PSP)

The American Food and Drug Administration (FDA) has granted AZP2006 the Orphan Drug Designation for the Treatment of Progressive Supranuclear Palsy (PSP)

Loading posts...

« Previous 1 … 446 447 448 449 450 … 635 Next »